These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 30527792)

  • 61. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
    Ohtani T; Sintoku R; Yajima T; Kaneko N
    J Med Case Rep; 2019 Dec; 13(1):390. PubMed ID: 31875786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients.
    Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1852-8. PubMed ID: 26044231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
    Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
    Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-Term Prognosis in Ischemic Stroke Patients Treated with Intravenous Thrombolytic Therapy.
    Stefanovic Budimkic M; Pekmezovic T; Beslac-Bumbasirevic L; Ercegovac M; Berisavac I; Stanarcevic P; Padjen V; Jovanović DR
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):196-203. PubMed ID: 28341074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Platelet-to-White Blood Cell Ratio: A Prognostic Predictor for 90-Day Outcomes in Ischemic Stroke Patients with Intravenous Thrombolysis.
    Chen Z; Huang Y; Li S; Lin J; Liu W; Ding Z; Li X; Chen Y; Pang W; Yang D; Su Z; Li J; Weng Y; Zhang X
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2430-8. PubMed ID: 27372596
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous Thrombolysis Guided by Perfusion CT with Alteplase in >4.5 Hours from Stroke Onset.
    Medina-Rodriguez M; Millan-Vazquez M; Zapata-Arriaza E; Escudero I; Pardo-Galiana B; Cabezas-Rodriguez JA; Lebrato-Hernandez L; Ortega-Quintanilla J; de Albóniga-Chindurza A; Ocete-Perez RF; Jurado-Serrano J; Gonzalez-Garcia A; Cayuela A; Moniche F
    Cerebrovasc Dis; 2020; 49(3):328-333. PubMed ID: 32615572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X; George MG; Yang Q; Gillespie C
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis.
    Kurowski D; Jonczak K; Shah Q; Yaghi S; Marshall RS; Ahmad H; McKinney J; Torres J; Ishida K; Cucchiara B
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1104-1109. PubMed ID: 28110890
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion.
    Kahles T; Mono ML; Heldner MR; Baumgartner RW; Sarikaya H; Luft A; Bohlhalter S; Traenka C; Engelter ST; Kurka N; Köhrmann M; Curtze S; Michel P; Tatlisumak T; Nedeltchev K
    Stroke; 2016 Aug; 47(8):2133-5. PubMed ID: 27364530
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
    Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Systemic thrombolysis after the administration of idarucizumab in acute ischemic stroke].
    Pásztor M; Bereczki D; Szakács Z; May Z
    Ideggyogy Sz; 2017 Jul; 70(7-8):284-288. PubMed ID: 29870643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
    Huisa BN; Raman R; Neil W; Ernstrom K; Hemmen TM
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
    Ranasinghe T; Mays T; Quedado J; Adcock A
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.